Tax group blasts Pfizer, urges stop to its tax-cutting deal
A consumer group is accusing Pfizer of seeking to avoid $35 billion in U.S. taxes with its plan to buy fellow drugmaker Allergan in a deal structured to nominally move Pfizer's address to lowe…